Britain's National Health Service To Offer Obesity Drug

10/17/2001 | BBC

Britain's National Institute for Clinical Excellence has recommended that Reductil, a highly effective anti-obesity drug, should be made available on its National Health Service to adults age 18-65 who have diabetes or high cholesterol and have made serious attempts to lose weight. Patients who take the drug lose about 8% of their body weight after two years.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Director, Site Quality Management
Minneapolis, MN
Clinical Project Manager
Abiomed, Inc.
Danvers, MA
Sr. Manager, Regulatory Affairs - International
Integra LifeSciences
Plainsboro, NJ
Associate - Food and Drug
Keller and Heckman LLP
Washington, DC
In house Compliance Officer
Pompano Beach, FL